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Abstract
Background: Two phenylalanines (FF)i na nacidic tract (FFAT)-motifs were originally described as having seven elements:
an acidic flanking region followed by 6 residues (EFFDA–E). Such motifs are found in several lipid transfer protein (LTP)
families, and they interact with a protein on the cytosolic face of the ER called vesicle-associated membrane protein-
associated protein (VAP). Mutation of which causes ER stress and motor neuron disease, making it important to determine
which proteins bind VAP. Among other proteins that bind VAP, some contain FFAT-like motifs that are missing one or more
of the seven elements. Defining how much variation is tolerated in FFAT-like motifs is a preliminary step prior to the
identification of the full range of VAP interactors.
Results: We used a quantifiable in vivo system that measured ER targeting in a reporter yeast strain that over-expressed VAP
to study the effect of substituting different elements of FFAT-like motifs in turn. By defining FFAT-like motifs more widely
than before, we found them in novel proteins the functions of which had not previously been directly linked to the ER,
including: two PKA anchoring proteins, AKAP220 and AKAP110; a family of plant LTPs; and the glycolipid LTP
phosphatidylinositol-four-phosphate adaptor-protein-2 (FAPP-2).
Conclusion: All of the seven essential elements of a FFAT motif tolerate variation, and weak targeting to the ER via VAP is
still detected if two elements are substituted. In addition to the strong FFAT motifs already known, there are additional
proteins with weaker FFAT-like motifs, which might be functionally important VAP interactors.
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Introduction
The function of intracellular proteins is largely determined by
their precise targeting within cells, and recruitment of cytoplasmic
proteins to membranes contributes a major part of organellar
identity [1]. Peripheral membrane proteins make up a large
proportion of overall membrane-associated protein [2], and often
bind with a moderate affinity (micromolar to nanomolar
dissociation constants) allowing regulatable and reversible recruit-
ment. The membrane receptor can be a lipid or protein, and often
a combination of more than one, allowing targeting by co-
incidence detection [3]. Recruitment of cytoplasmic proteins to the
endoplasmic reticulum (ER) has been demonstrated for compo-
nents of ER membrane complexes that mediate (retro-) translo-
cation [4,5], and vesicle fission/fusion [6,7].
While many proteins on the ER can recruit a small number of
cytoplasmic binding partners, one pair of ER proteins recruits a
wide range of partners: vesicle-associated membrane protein-
associated protein (VAP)-A and VAP-B are highly homologous
,240 a.a. proteins conserved in all eukaryotes consisting of a
single transmembrane helix anchoring a cytoplasmic domain
[8,9]. VAPs are important partly because dysfunction of VAP-B
causes motor neuron disease [10], with one proposed mechanism
being that lack of VAP-B causes ER stress [11,12,13]. Both VAPs
bind with micromolar dissociation constants to FFAT motifs,
standing for two phenylalanines (FF)i na nacidic tract [14,15,16],
motifs that occur in many different proteins (see below). However,
it is not known which of the many interactions of VAP-B is related
to motor neuron function, and importantly the full extent of VAP
interactions has not been established.
The FFAT motif was precisely defined as
1EFFDA-E
7
appearing in highly acidic, unstructured regions of multidomain
cytoplasmic proteins [14,15]. Each residue in the motif is involved
in side-chain specific interactions with VAP [15]. There are six
types of FFAT proteins, four of which interact with lipids: (1) the
transcription factor Opi1p in yeast that binds phosphatidic acid
[17]; (2) CERT, a lipid transfer protein (LTP) for ceramide by
virtue of its StART domain [18]; (3) oxysterol binding protein-
related proteins (ORPs), that have an LTP domain specific for
sterols [19,20]; (4) the phosphatidylinositol transfer protein
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have now all been shown to be functional in the context of
full-length protein, leading to complex formation with VAP
[17,22,23,24,25,26]. However, the full-length proteins are still not
clearly seen on the ER, with the sole exception of Opi1p. Instead,
they often strongly target other sites (TGN, plasma membrane,
late endosome). Despite this, FFAT motifs have been shown to be
critical for function both in yeast and mammalian LTPs
[14,25,26,27], so it is thought that targeting to the ER occurs,
but is hard to detect because the subdomains of ER involved form
membrane contact sites with the TGN or plasma membrane
[28,29].
FFAT-like motifs differ from the canonical
1EFFDA-E
7, but the
degree of allowed difference has never been studied. FFAT-like
motifs in ORPs show marginal difference from FFAT, and bind
VAP tightly [23,26,30]. Although some VAP interactors, have no
discernible motif like FFAT [31,32,33,34], there are other examples
of VAP interactors that have been suggested to contain FFAT-like
motifs [35,36,37]. One is protrudin, an integral membrane protein
that binds rab11 and migrates from the ER to endosomes, and
which contains
1EFKDA-E
7 [35,38]. Anotherexample isGlycolipid
LTP (GLTP), a 209 a.a. protein that transfers glycolipids such as
glucosylceramide (GlcCer) between membranes [39]. GLTP
interacts directly with VAP, and a FFAT-like motif was identified
in GLTP:
32PFFDC-G
38, which has the
2FFD
4 core [37]. Similarly,
Orp3a, one of 12 ORPs in Arabidopsis, binds VAP via a small region
within the ORP domain that has features of the FFAT core:
2WFD
4
[36]. In protrudin, GLTP and Orp3a, mutations in the identified
FFAT cores inhibited function, suggesting that FFAT-like motifs
can vary considerably from
1EFFDA-E
7 and still be physiologically
relevant. This opens the question of how many proteins might be
interacting with VAP, as sequences resembling the core
2FFD
4 are
extremely common(,3,500 in humans), but only a small fraction of
these are likely to be relevant.
Here, we started to define how much variation FFAT-like motifs
can tolerate away from the optimal, canonical sequence. By
studying increasingly divergent FFAT-like motifs, we have shown
that each of seven elements of FFAT motifs (the six key residues
plus the acidic flank) can be substituted, sometimes one element
very suboptimally, or two elements both affected marginally. This
approach led us to identify new proteins with FFAT-like motifs of
varying strengths. Strong FFAT-like motifs in two of the 14 protein
kinase A anchoring proteins (AKAPs) [40] tested positive for
binding to VAP. A much weaker FFAT-like motif was found in the
GLTP family member FAPP2. Sequences of LTP families
particularly in plants, revealed new FFAT-like motifs. By
comparing all examples of FFAT-like motifs, we developed an
algorithm to score new sequences. This showed that while
canonical FFATs make up the majority of strong interactors of
VAP, there is a moderate number of new proteins with FFAT-like
motifs that potentially target VAP. These merit further study as
they may contribute to the role of VAP in ER stress.
Results
1. Variation at every residue is found in FFAT-like motifs
The canonical FFAT motif
1EFFDA-E
7 occurs in 29 eukaryotic
cytoplasmic proteins, which are in 6 families: four lipid binding
proteins (see above), (5) the worm homologue of Rab3GAP1, and
(6) rabphilin-11 [14]. FFAT-like motifs with conservative substi-
tution at a single position in
1EFFDA-E
7 are found in homologues
of ORPs, rdgB, Rab3GAP1 and rabphilin-11. These natural
substitutions are: E
1RD, F
2RY, F
3RY, D
4RE, A
5RC, E
7RD, S
or T [14]. The upstream flanking acids are conserved in all of
these FFAT-like motifs. If all these single substitutions are
tolerated, there are 127 variant combinations that might bind
VAP. To gauge the importance of these variants, we identified
where any of these 127 variations appeared in eukaryotic proteins.
Only 30 of the possible 127 variant motifs were found, appearing
69 times. Twenty of these 69 hits are homologues of ORPs, rdgB,
Rab3GAP1 and rabphilin-11. Although the effect of some of the
variations (D
4RE, A
5RC) has not yet been reported, this
conservation of FFAT-like motifs in protein families is a strong
indicator that the key elements of the motif are functionally
important. Apart from the twenty hits already known to us, there
are 49 proteins with possible FFAT motifs containing one or more
of the conservative variations (Table S1). These are analysed in
greater detail in Section 4 (below).
To test if the natural variation in these FFAT-like motifs affects
ER targeting, we expressed the region of human Rab3GAP1 that
contains the FFAT-like motif
1EFFEC-S
7,w i t hD
4RE, A
5RCa n d
E
7RS substitutions. The region surrounding the motif is highly
acidic, and is predicted to form an unstructured loop (Table 1). We
expressed this region in a GFP-tagged construct in a yeast strain that
has inducible over-expression of Scs2p, the major yeast VAP
homologue [14,41]. The region of Rab3GAP1 targeted GFP to the
ER, with fluorescence enriched at the nuclear envelope (NE), in
patches in the periphery and in occasional strands crossing the
cytoplasm (Figure 1A), a pattern highly characteristic of the ER in
yeast. By comparison, GFP tagged with an irrelevant sequence failed
to target any of these sites, with diffuse fluorescence (Figure 1B). As is
characteristic for GFP itself, the negative control construct was
slightly concentrated in the nucleus [42]. Similar diffuse targeting
was seen with GFP-FFAT constructs when expressed in the same
cells with repressed expression of VAP (data not shown), as found
previously [14]. ER targeting by
1EFFEC-S
7 from Rab3GAP1 is as
strong as any FFAT motifs tested previously [14,41], showing that
FFAT-motifs tolerate E
4,C
5 and S
7. This result is similar to the
strong binding to VAP seen previously for
1EFYDA-S
7 in human
ORP1,varyingatpositions3and 7[30].Thus,multipleconservative
substitutions are tolerated in FFAT-like motifs.
We next studied the requirements for an acid at position 4,
which we reported previously to be essential for ER localization
[14]. Indeed, a Rab3GAP1 construct mutated E
4RA(
1EFFAC-
S
7) showed much reduced ER targeting (Figure 1C). To quantify
the reduction in targeting, we used the least ambiguous aspect of
ER targeting in confocal sections, which is the ring staining of the
NE. Analyzing fluorescence across nuclear profiles on a cell by cell
basis, ER targeting was calculated as the ratio of fluorescence on
the NE to the central portion of the nucleus (Figures 1D/E/F). In
making these analyses, we noted that the extent of NE targeting
was lower in cells expressing more construct (Figure 1D). This
shows that positive targeting was saturable, and indicates that
FFAT proteins are capable of competing with each other.
The average ratio from multiple cells was calculated as targeting
strength ratio (TSR, see Materials and Methods). To verify this
approach we expressed a 110 residue region of Osh1p that
contains one of the optimal FFAT motifs (Figure S1) [14]. Clear
targeting of the FFAT-region of Osh1p was seen with high Scs2p,
and the corresponding to TSR was 1.59. For the same construct in
the same strain of yeast grown to repress Scs2p, the TSR was 0.90.
A similar TSR was obtained with a negative control construct (Px
domain of Bem1p) expressed in cells with high Scs2p, with
TSR=0.92 (Table 1). The reason that TSR was less than one for
inactive sequences is likely to be that out of plane fluorescence
makes the central portion of nuclei brighter than the perimeter.
Now turning to the new FFAT-like motif, the Rab3GAP1
construct demonstrated stronger targeting than the Osh1p
FFAT-Like Motifs
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D
4RA variant showed that it was not entirely negative:
TSR=1.12 (Table 1), significantly higher than control (Student’s
T-test: p,10
28). Substituting four upstream SRE did not increase
NE targeting of the D
4RA variant (Table 1), showing that
targeting was limited by lack of D
4, not overall acidity. A key
finding from quantitation is that, while D
4 or E
4 is required for a
strong interaction with VAP, a weak interaction can be obtained
without it. If such weak interactions significantly increase the dwell
time of cytoplasmic proteins on the ER, then potentially a very
large number of FFAT-like motif variants could be active.
2. FFAT-like motifs in AKAPs – wider natural variation at
positions 3, 4 and 5
To begin to identify the far wider range of weaker FFAT-like
motifs, we first searched for proteins with FFAT-like motifs as
Table 1. Targeting strength ratios (TSRs) and number of suboptimal residues for all the FFAT-motifs studied.
Source Core Sequence Flanks local± H TSR #subopt
amino FFAT-like carboxy before after
Osh1-110+GAL EDSDaD EffDaEE AA 23 72 -5 1.59 0
Osh1-110+DEX EDSDaD EffDaEE AA 23 72 -5 0.90 0
Bem1p-Px negative control / / / 0.92 /
Rab3GAP1-wt wSDSEE EffEclS DT 8 3 -4 1.76 0.5
Rab3GAP1-4A wSDSEE EffaclS DT 8 3 -4 1.12 1.5
Rab3GAP1-4Ae wEDEEE EffaclS DT 8 3 -6 1.08 1.5
AKAP220-wt SDSEvS EffDSfD QF 5 9 -2 H 1.34 1
AKAP220–5E SDSEvS EffDEfD QF 5 9 -2 H 0.91 2.5
AKAP220–5A SDSEvS EffDafD QF 5 9 -2 H 1.96 0.5
AKAP110-wt lSSiEE DflTaSE HL 8 9 -2 H 1.17 2
AKAP110-4D lSSiEE DflDaSE HL 8 9 -2 H 1.32 1.5
AKAP110-4A lSSiEE DflaaSE HL 8 9 -2 H 0.99 2.5
Orp1c:Gm-wt TDDDDN affDTRD IL 14 5 -4 1.36 1.5
Orp1c:Gm-AA TDDDDN aaaDTRD IL 14 5 -4 0.89 4.5
Orp1c:Gm-1M TDDDDN mffDTRD IL 14 5 -4 1.34 1.5
Orp1c:Gm-1H TDDDDN hffDTRD IL 14 5 -4 1.11 1.5
Orp1c:Gm-1K TDDDDN kffDTRD IL 14 5 -4 1.01 2
Orp1c:Gm-1M4N TDDDDN mffnTRD IL 14 5 -4 1.02 2.5
Orp2a:At-wt SEEDEp SfhDTKE FF 9 8 -4 0.94 2.5
Orp2a:At_x2 SEEDEp SfhDTKE FF 9 8 -4 1.33 (2.5)
Orp2a:At_x2-AA SEEDEp SaaDTKE FF 9 8 -4 0.94 (4)
Orp2a:At_x2-1D SEEDEp DfhDTKE FF 9 8 -4 1.36 (2)
Fapp2:Md-wt EEEEvq TffSamn ED 8 9 -6 0.90 2
Fapp2:Md-1E EEEEvq EffSamn ED 8 9 -6 0.94 1.5
Fapp2:Md-4D EEEEvq TffDamn ED 8 9 -6 1.11 1.5
Fapp2:Md-1E4D EEEEvq EffDamn ED 8 9 -6 1.11 1
Fapp2:Hs_x2-wt gKEvip TffSTmn TS 13 9 0 1.00 (4)
Fapp2:Hs_x2-1E4D gKEvip EffDTmn TS 13 9 0 0.90 (3)
Fapp2:Hs_x2-EDA gKEvip EffDAmn TS 13 9 0 1.35 (2.5)
Fapp2:Hs_x4-wt gKEvip TffSTmn TS 13 9 0 0.82 (4)
Fapp2:Hs_x4-4D gKEvip TffDTmn TS 13 9 0 1.15 (3.5)
MAST205-wt ESEDDT SyfDTRS ER 6 15 -4 0.90 2.5
Src-5A lqaflE DyfTaTE PQ 10 7 -1 H 0.87 3
Ypt11p-wt qghEqQ EfhDTvE EP 22 4 -2 H 0.86 3.5
The core FFAT-like motifs and immediate neighbours (6 amino-terminal and 2 carboxy-terminal) are shown for all sequences expressed in this study. Residues that
might contribute to local charge (D, E, S, T, K or R) are in capitals, all others in lower case. Residues in bold indicate substitutions tested in this study. The number of
other residues in the flanks of expressed constructs is also given. Full sequences and their precise origins are given in Table S5.
‘‘local 6’’ is the sum of charges in eight residues flanking the motif (six before and two after): K/R=+1 and D/E= –1.
‘‘H’’ indicates that the region is predicted to be helical, in bold if known to be helical in structural studies (details in Table S2).
‘‘TSR’’ is the ‘‘Targeting Strength Ratio’’ measured from nuclear profiles (see Materials & Methods), indicating the strength of NE targeting.
‘‘# sub-opt’’ is the number of sub-optimal elements in each motif, determined according to the method set out in Table S2. Lower scores indicate a more optimal motif.
Where the motif tested was multimerized the figures are in brackets, as they are not directly comparable.
doi:10.1371/journal.pone.0030455.t001
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5 RS/T. Among
105 hits in total (14 in humans), one was AKAP220 (also called
AKAP11), which has
1EFFDS-D
7 in an acidic region near its
amino-terminus. We expressed this region in cells, together with
variants at S
5RE and S
5RA.
1EFFDS-D
7 targeted the ER
moderately, TSR=1.3, showing that S
5 is tolerated (Figure 2A).
S
5RE completely inhibited ER targeting (TSR=0.9, Table 1),
suggesting that phosphorylation at position 5 could be used to
regulate FFAT-like motifs with S/T
5. In contrast, S
5RA
enhanced targeting, producing the highest TSR of all motifs in
this study (TSR=1.96, Figure 2A, Table 1).
Examination of the rest of the amino-terminus of AKAP220
revealed a second FFAT-like motif nearby:
1DFVTA-E
7. Not only
are both motifs conserved in AKAP220 in other species (e.g. fish),
but the second motif is conserved in the protein most closely
related to AKAP220: AKAP110 (also called AKAP3, FSP95,
fibrousheathin-1, SKIP, and SPKAP) has
1DFLTA-E
7. These
motifs are interesting as they have two substitutions: F/Y
3 R non-
aromatic hydrophobic residues and D/E
4 R T. In yeast, the
region from AKAP110 targeted VAP weakly (TSR=1.2,
Figure 2B). We tested if phosphorylation of S
4 or T
4 is one
mechanism to regulate VAP binding by this FFAT-like motif, and
found that the T
4D variant targeted significantly better than the
original sequence (TSR=1.3), while the T
4A variant largely failed
to target (TSR=1.0, Figure 2B, Table 1). Therefore, while T
4 is
tolerated, pseudo-phosphorylation of T
4 increases ER targeting.
These results show that two AKAPs in humans might be recruited
Figure 2. FFAT-like motifs in two AKAPs. (A) 29 amino acids from
AKAP220 including the FFAT-like motif
1EFFDS-D
7 (see Table 1) were
expressed as in Figure 1A, together with variants at position 5:
1EFFDE-
D
7 and
1EFFDA-D
7. The wild-type (WT) sequence showed moderate
targeting, which was lost with E
5 and enhanced by A
5. (B) 32 amino
acids from AKAP110 including the FFAT-like motif
1DFLTA-E
7 (see
Table 1) were expressed as (A), together with variants at position 4:
1
DFLDA-E
7 and
1 DFLAA-E
7. The wild-type (WT) sequence showed weak
targeting, which was enhanced by D
4 and lost with A
4.
doi:10.1371/journal.pone.0030455.g002
Figure 1. The FFAT-like motif of Rab3GAP1 targets VAP. (A) 26 amino acids including the FFAT-like motif
1EFFEC-S
7 from Rab3GAP1 (see
Table 1) were tagged with GFP and expressed in TLY251, which was grown in galactose to induce maximal yeast VAP (Scs2p) expression. Confocal
sections through the plane of the nuclei showed the GFP construct interact with Scs2p, as fluorescence was found on the nuclear envelope (NE), in
patches in the cell cortex, and in occasional strands in the cytoplasm, a pattern highly characteristic of the ER in yeast. Arrows indicate cells likely
where the nucleus has been optically sectioned off the mid-line, so increasing central fluorescence and underestimating targeting. (B) As A, except
GFP was tagged with the Px domain of Bem1p. This construct did not target membranes. (C) As A, except the FFAT-like sequence was altered at
position 4:
1EFFAC-S
7. ER targeting is barely detectable, but much weaker. (D/E/F) Fluorescence was measured across nuclear profiles from (A) (B) and
(C) respectively, (examples shown in the insets, above). Line scans were re-plotted to normalise for different nuclear widths, and profiles from five
nuclei are shown.
doi:10.1371/journal.pone.0030455.g001
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[43], and also the results suggest a much broader molecular
definition of FFAT motifs should be considered.
3. FFAT-like sequences in plant LTPs with natural
variation in positions 1, 3 and 5
Among the 15 human LTPs that contain StART domains only
CERT has a FFAT motif [44]. StART domain proteins are
amplified in plants (35 in Arabidopsis) [44], but none contain FFAT
motifs. Using the wider definitions from our work on AKAPs, we
noted that three of the sub-group of five plant StART proteins
including Enhanced Disease Resistance (Edr)-2 have FFAT-like
motifs with single substitutions E
1RQo rA
5RV (Figure 3A). Also
in plants, our original study had suggested a possible FFAT-like
motif in a conserved acidic region in A. thaliana Orp1c. We now
realise that the motif we predicted before (
1EEFDE-E
7) is likely to
fail on account of both E
2 and E
5. However, directly adjacent to
this is the sequence
1TFFDT-D
7, which was not originally obvious
as a FFAT-like motif, but includes the
2FFD
4 core. Among other
A. thaliana ORPs, Orp1d is similar to Orp1c with
1PYFDT-D
7,
Orps2a/2b have
1SFHDT-E
7, and Orp1a has the acidic tract but
the motif is highly altered to
1QFDEA-E
7 (Figure 3B). FFAT-like
motifs at this site in ORPs of other plants naturally vary at position
1 to any of AEHILMPST (Figure 3B). Similar variation is also
seen in diverse ORPs in other species (Figure 3B), in plant
homologues of the FFAT protein rabphilin-11, a WD repeat
protein implicated in vesicular trafficking (Figure 3C) [45,46], and
in a fungal homologue of Opi1p (Figure 3D), with position 1 any
of EHIKLQRTVW. These natural variants imply that any residue
is tolerated at position 1, particularly in plants.
We examined putative plant FFAT-like motifs to test the
significance of variation at position 1. First we expressed
1AFFDT-
D
7 from Orp1c in Glycine max (soybean). This targeted moderately
well (Figure 3E, TSR=1.36, Table 1). Mutation of the key
residues
2FF
3 reduced targeting to background levels (Figure 3E,
Table 1), demonstrating the expected specificity of interaction. We
varied position 1, and found that a hydrophobic residue
(
1MFFDT-D
7) had no effect on targeting, while H
1 reduced
targeting (Table 1). Introduction of K
1, the polar opposite of the
typical acid, reduced targeting to a barely detectable level
(TSR=1.01, Figure 3E, Table 1). Although targeting was above
background (p=5610
24), K
1 was quite inhibitory (Table 1). This
shows that a highly unfavourable substitution at position 1 can
inhibit binding considerably, even though this position is the least
constrained of the seven elements of a FFAT motif residue [15].
Given that a F
3H substitution is found in a C. elegans homologue
of oxysterol binding protein [14], we decided to test the FFAT-like
motif in A. thaliana Orp2a and Orp2b:
1SFHDT-E
7 with highly
acidic flanks. When expressed in cells, this showed no ER targeting
(Figure 3E, Table 1, TSR=0.94, not significantly above
background). To detect any weak targeting that might exist for
this motif, we expressed a construct containing two of the motifs as
a tandem dimer, similar to the approach used to enhance weak
targeting of PH and FYVE domains [47,48]. Dimerization is used
here to increase avidity, and this reproduces aspects of the in vivo
situation, since VAP in many species (but not yeast) dimerizes [49].
Dimeric
1SFHDT-E
7 showed moderate NE targeting (Figure 3E,
Table 1). The specificity of this was shown by loss of targeting with
dimeric
1SAADT-E
7 (Figure 3E, Table 1), which indicates that the
binding does not result solely from the increased electrostatic
interaction of the double motif (overall charge 220). The
functional effects of clustering of Scs2p by the dimeric motif are
unknown, but the clustering is unlikely to be critical for binding,
given that strong interactions occur with monomeric FFAT motifs.
Since
1SFHDT-E
7 could be phosphorylated at position 1 to mimic
the canonical D/E, we tested the effect of a S
1D substitution in
dimers. This did not enhance targeting over wild-type (Table 1).
This is consistent with S
1 already being phosphorylated in yeast;
this residue is a predicted Casein Kinase II site. Thus, 4 of the 12
plant ORPs have FFAT-like motifs, which are active even with
three substitutions: S
1,H
3 and T
5. Again this suggests that many
substitutions in FFAT motifs are tolerated if other residues are
optimal.
4. Assessing the extent of FFAT-like sequences in all
human proteins
Our findings above show that FFAT-like motifs can tolerate
multiple substitutions. In another study, the endosomal regulator
protrudin (also called ZFY27) was found to contain a FFAT-like
motif
1EFKDA-E
7, which binds to VAP, and is inhibited by a D
4A
mutation, despite the F
3RK substitution [35].This shows that
FFAT-like motifs also tolerate single extreme substitutions,
Therefore, we then used our knowledge of substitutions at each
position in the motif to generate a simple tool to assess how
optimal any FFAT-like motif is overall (Table S2A, see Materials
and Methods). This tool was used to determine the number of
suboptimal elements in any putative motif, with the strongest
FFAT motifs scoring zero, and very poor motifs scoring up to
seven. To check the tool, we first scored the FFAT-like motifs that
we had expressed in yeast (Table 1, final column). This showed
that FFAT-like motifs that target at barely discernible levels tend
to score 2 suboptimal elements, but that lack of $2.5–3 elements
inhibited targeting. Next, we applied these requirements to score
FFAT-like motifs in all human proteins. We limited these searches
to human proteins since there would have been too many
sequences to handle (.20,000) if the entire database was queried.
Using a cut-off of #2 suboptimal elements, 76 human sequences
were found, including all of the 14 human FFAT motifs identified
originally [14,15], and 62 new FFAT-like motifs. Increasing the
cut-off even marginally would identify many more putative FFAT-
like motifs (Table S2B).
Pooling the 62 new human FFAT-like motifs with 2 or less
elements missing together with the 49 new motifs from all species
containing one of the 127 simple variant FFAT-like motifs (Table
S1), and discounting repeats, we arrived at a list of 79 proteins with
new possible FFAT-like motifs (Table S3). Four criteria were then
applied, where likely interactors have to meet all four: (A) they are
cytoplasmic; (B) they do not definitely form helices in known
crystal structures of homologous domains, as helical arrangement
of the motif will not allow it to extend across its binding site in
VAP [15,30]; (C) the critical residues of the FFAT-like motifs are
conserved among orthologues more than the neighbouring
residues; and (D) the motifs have 2 or fewer elements missing,
this being the cut-off we determined for detectable targeting
(Table 1). This criterion had to be applied to the 49 motifs
identified in Table S1, because firstly some of the natural
variations appear suboptimal, in particular F
2RY, but also
F
3RY and E
7RS/T, and secondly their flanks were not all
acidic. For example, EFYDA-S in Rad2p (yeast) is preceded by
HEKNYV. Where structure was predicted, but not known from
direct study, predictions were not used to exclude a motif. The
four criteria were met by AKAP220, AKAP110, protrudin and 18
proteins previously not known to contain FFAT-like motifs (Table
S3). 58 remaining proteins with FFAT-like motifs failed to meet
one or more criterion (Table S3).
The 18 motifs that meet all our criteria are good candidates for
interactors of VAP. Among these, only three proteins contain a
motif very close to the optimum, (i.e. missing one element or less):
FFAT-Like Motifs
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one of four human homologues of yeast Vps13p, which is a
cytoplasmic protein .3000 a.a. implicated in membrane traffick-
ing. Vps13C has a FFAT-like sequence in a predicted unstruc-
tured loop, and a very similar motif is present in the same loop of
Vps13A (also called chorein), the closest homologue of Vps13C
[50]. Similar FFAT-like motifs are found in most vertebrate
Vps13C orthologues, in distantly related organisms such as slime
Figure 3. FFAT-like motifs in plant ORPs. (A–D) Aligned FFAT-like motifs from (A) the subfamily of StART proteins related to Edr2 in Arabidopsis
thaliana (At); as shown in the diagram, this region is between the StART domains and DUF1336, which are domains of unknown function structurally
related to galectins. (B) ORPs. FFAT-like motifs, which occur upstream of ORP domains. Top: in At and homologues in other plants: Gm – Glycine max;
Os – Oryza sativa; Zm – Zea mays; Vv – Vitis vinifera; Pi – Petunia integrifolia; bottom: in other species, as listed. (C) homologues of rabphilin-11from
human, fish (one each) and At (x7). These motifs are at the extreme amino-termini. (D) Opi1p in the fungus Ashbya gossypii. (E) 34 amino acids from
Orp1c (Gm) including the FFAT-like motif
1AFFDT-D
7 were expressed as in Figure 1A, together with variants
1AAADT-D
7 and
1KFFDT-D
7. The wild-
type (WT) sequence showed moderate targeting, which was lost with
2AA
3 and reduced with K
1. (F) 32 amino acids from Orp2a (At) including the
FFAT-like motif
1SFHDT-E
7 were expressed as in (E) (left hand panel). We also expressed the dimer of this motif, and a dimer of a mutant:
1SAADT-E
7
(middle and right panels, images are at 2-fold lower magnification. The wild-type (WT) monomer failed to target, but moderate targeting was
obtained upon dimerization, which was lost with
2AA
3.
doi:10.1371/journal.pone.0030455.g003
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member 15), is a 12 transmembrane helix protein. It has a FFAT-
like motif in the 60 a.a. cytoplasmic domain at its extreme
carboxy-terminus, and the motif in Flipt is conserved in all its
orthologues, but not found in the .20 other SLC22 family
members. Rhophilin-1 and its orthologues interact with Rho-
GTPase, and contain a strong FFAT-like motif in a region
predicted to be unstructured. Since the motif in AKAP220 is able
to target VAP, we predict that the motifs in Vps13C, Flipt and
rhophilin-1 can also bind VAP, and that these proteins are at least
partially targeted to the ER. Interestingly, rhophilin-1 also binds
ropporin, which itself interacts with AKAP110 [51,52], suggesting
that two components of the same complex can both interact with
VAP.
Another way to identify proteins with FFAT-like motifs is to
look for motifs among VAP interactors identified in high-
throughput experiments. The BIOGRID database lists 13
interactors for VAPB (Figure S2A), two of which have FFAT-
like motifs. One is USP20 [53], one of the large family of
deubiquitinases. USP20 has a long unstructured loop with a
slightly sub-optimal FFAT-like motif (
282EFLSC-S
288) that is
reasonably conserved in all orthologues (Figure S2B). A weaker
FFAT-like motif is also found in USP33, the closest homologue of
USP20 (Figure S2B). The second VAP interactor with a FFAT-like
motif is the Regulator of Microtubule Dynamics-3 (RMD3, also
called PTPIP51 or FAM82A2) [54], an integral membrane protein
on the outer face of mitochondria. While this paper was in
revision, RMD3 was shown to bind VAPB across ER-mitochon-
drial contact sites to modulate calcium traffic from ER to
mitochondria [55]. Although not commented on in that paper,
we noted that the minimal portion of human RMD3 required for
VAP binding (residues 84–175) contains not one but two FFAT-
like motifs, one of which (
157VYFTASS
163) is highly conserved in
all RMD3 orthologues. One of these contains the strong motif
1EFYEA-Q
7 (Figure S2C). RMD2, a close homologue of RMD3,
also contains a relatively active FFAT-motif, so RMD2 (but not
RMD1) may be participating in the same functions as RMD3.
Although we have not tested the FFAT-like motifs in USP20 and
RMD3, our analysis suggests a possible mechanism to regulate the
function both of USP20 in receptor recycling [56] and of RMD3
in apoptosis [55]: by phosphorylation of their FFAT-like motifs.
5. FFAT-like sequences in short and long isoforms of
GLTP indicate three possible locations for FFAT-like
motifs in GLTP and FAPP2
Compared to CERT and ORPs with canonical FFAT motifs,
GLTPs do not obviously contain a FFAT motif, even though they
are implicated in similar pathways of intracellular traffic [57,58].
Human GLTP binds VAP via
1PFFDC-G
7 (residues 32–38), a
motif that contains the FFAT core
2FFD
4 [37], but is missing three
of the key FFAT elements (Table S4). Examining sequences
similar to
1PFFDC-G
7 in the amino-terminus of diverse GLTP
sequences, we found a previously unreported FFAT-like motif just
upstream (Figure 4A). In some GLTPs (for example, from the
fungus Debaryomyces), this motif is closer to optimal than the
downstream one (Table S4). This implies that GLTPs have
multiple weak FFAT-like motifs that may act in concert.
GLTPs have short and long isoforms (Figure 4A), the former
consisting of the LTP domain alone, the latter extended to include
a PH domain that targets the TGN, hence called phosphatidy-
linositol-four-phosphate adaptor-protein-2 (FAPP2) [59]. This
same pattern of short and long isoforms is also seen with CERT
and ORPs [44,60]. FAPP2 functions to traffic GlcCer, which is
made in the Golgi [57,59]. However, it is controversial where
GlcCer is delivered by FAPP2, possibilities including the TGN
[57], or the ER [58]. We therefore asked if FAPP2 shares another
property of CERT and ORPs, namely does it contain a FFAT-like
motif to target the ER? An alignment of diverse FAPP2 and GLTP
sequences showed that some FAPP2s share the FFAT-like motifs
found in GLTP. Furthermore, some FAPP2s have another
previously unreported FFAT-like motif upstream of the other
two (Figure 4A). We scored the three potential motifs in this region
for how many elements are optimal. Significantly, some of the new
FFAT-like motifs in FAPP2 score similarly to the GLTP motif that
is functionally relevant (Table S4) [37], so they might also
contribute to function.
To test if FAPP2 can bind VAP, we expressed the most optimal
mammalian FAPP2 motif,
1TFFSA-N
7, which occurs in marsu-
pials such as opossum (Figure 4B). This did not target the ER
(Figure 4C), neither did a
1EFFSA-N
7 variant that mimics
phosphorylation at T
1 (data not shown). However, pseudo-
phosphorylation of S
4 with
1TFFDA-N
7 did produce a weak
interaction with VAP, as did the double substitution
1EFFDA-N
7
(Figure 4C, Table 1). This shows that if FAPP2 in species such as
opossum was phosphorylated at S
4 of this motif (S317), the whole
protein might be recruited to the ER. The FFAT-like motif of
FAPP2 in humans (
1TFFST-N
7) is less optimal than in opossum in
2 elements: fewer flanking acids, and A
5RT (Figure 4A). Since T
5
can be tolerated (Fig. 3), we investigated ER targeting of this
region. Both the wild-type sequence and a variant with two
pseudo-phosphorylations (
1EFFDT-N
7) failed to target VAP on
the ER (data not shown). Also a dimeric version of the latter motif
showed no ER targeting, and only after adding in a third change
T
5RA did we detect ER targeting (Figure 4D, Table 1).
The finding that the dimeric human FAPP2 sequence only
targets when it has A
5 suggests that it is far from optimal.
Nevertheless, because FAPP2 itself is normally dimeric [61],
together with VAP being dimeric [49], it is possible that a very
weak FAPP2-VAP interaction would be magnified by avidity
effects to become functionally significant. To attempt to model
these avidity effects, we expressed constructs with four copies in
series of the FAPP2 motif. Even though there is no evidence that
FAPP2 is tetrameric, and the tetramerization does not reproduce
the correct three-dimensional distribution, this will increase
avidity, as in the use of 13x-myc epitope tags [62]. Our result
with a tetramer of wild-type human FAPP2 motif was again that it
did not target (Table 1). However, tetrameric
1TFFDT-N
7 now
did weakly target the ER (Figure 4D, Table 1). Therefore, pseudo-
phosphorylation of S
4 in the FFAT-like motif of human FAPP2
does produce a weak interaction with VAP. This modification
could be the basis for a regulated interaction of FAPP2 with VAP
that enhances GlcCer traffic to the ER.
Discussion
Here, by testing a range of FFAT-like motifs, we have defined
which substitutions in this very small motif are neutral to ER
targeting, and which are sub-optimal. Even with sub-optimal
substitutions, strong targeting can occur if five or six of the seven
elements (6 key residues + acidic tract) are optimal. We still do not
know the full extent of allowed variation, but the highly
detrimental substitution F
3RK is allowed in protrudin [35],
showing that any single detrimental might be allowed. The
approach we used here was in vivo expression of regions of proteins.
Compared to an alternate approach of in vitro binding by peptides
to VAP, this has the advantage that post-translational modifica-
tions such as phosphorylation can occur. However, our experi-
ments fell short of providing dissociation constants, which would
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seven variant peptides, where single substitutions reduced the
affinity of binding between 2 and 15-fold [15]. Our experiments
suggest other peptides that might be tested in vitro. Also, we can
now suggest which full length proteins might be studied for direct
binding to VAP in vivo (Table S3). Prior identification of targets is
helpful because it has proved difficult to demonstrate interactions
of VAP with full-length proteins, even when they have strong
FFAT motifs that are known to be important for protein function
(for example: ORP9L [23,27]).
A major assumption that underlies our work is that the residues
on VAP that are involved in FFAT binding are conserved, so
allowing conclusions from binding to VAP in yeast to be applied to
proteins in all species. 11 residues have been identified in VAP that
contact FFAT motifs [15], and these are highly conserved in all
eukaryotes (Figure S3), so we have assumed that the requirements
for FFAT motifs are the same in all proteins, though this has not
been studied directly. Another issue to be considered is whether
VAP is restricted to the ER. There are reports of VAP outside the
ER [63,64], but this has not been reproduced more widely.
Instead VAP has been shown to move within the ER to membrane
contact sites, with the TGN, the plasma membrane and
mitochondria [20,25,55,65], and the VAP interactors are strong
candidates for proteins that bridge such contact sites [28]. Thus,
we hypothesize that all proteins containing functional FFAT-like
motifs will to some extent be components of the ER, including the
inner NE, since components of the nuclear transcriptional
machinery can bind VAP [66]. A point that might counteract
this is the possibility that proteins with FFAT-like motifs compete
for a limited number of VAP molecules. In yeast, where the
number of all proteins has been estimated, the copy number of
Scs2p only just exceeds that of all 4 proteins with strong FFAT
motifs [67], but we implicated an increasing number of proteins as
having FFAT-like motifs rises, it will become more important to
determine the extent of competition.
Some of the substitutions in FFAT-like motifs we have studied
allow direct phosphorylation that can modulate affinity for VAP.
Regarding residue 5 of the motif, our results with AKAP220
(Figure 2) are informative here. A
5 normally fits in a hydrophobic
pocket [15,30]. E
5 completely inhibited ER targeting, suggesting
that a negative charge is not tolerated in the pocket. This leaves
the question of why S
5 targets significantly worse than A
5. This is
unlikely to be caused by steric hindrance, because C
5, which is
larger than S
5, is well tolerated (Figure 1). Therefore, the weaker
targeting of S
5 compared to A
5 suggests that S
5 might be partially
phosphorylated in yeast, to mimic E
5. While there is no
experimental evidence for this phosphorylation, the upstream
residues partly match the consensus of ATM kinases, and although
ATM phospho-sites usually have Q at position +1, this is not
essential [68]. Therefore, phosphorylation of S
5 or T
5 remains a
possible (but untested) way in which FFAT-like motifs might be
negatively regulated. In contrast to inhibitory phosphorylation at
position 5, phosphorylation at positions 1, 4 and 7 may activate
FFAT-like motifs, in particular phosphorylation of core residue 4,
as in FAPP2 (S
4) and AKAP110 (T
4) (Table 1). In our assays, the
FFAT-like motif in vertebrate FAPP2 only functions if it is
activated by pseudo-phosphorylation. Presumably tyrosine phos-
phorylation can also regulate FFATs, which might explain why
many proteins have conserved Y
3 in place of the canonical F
3.
The FFAT-VAP interaction occurs in two stages: an initial
electrostatic interaction between the acidic tract and the
electropositive face of VAP is followed by a ‘‘fly casting’’ step,
with the core of the motif then binding by a lock-and-key
interaction with specific residues in VAP [15]. We have now found
several FFAT-like motifs which have second, weaker motifs nearby
in the sequence: in Arabidopsis Orp1d has
1DFYSV-S
7 30 residues
before
1PYFDT-D
7 and Orp2a/2b have
1EFEDV-E
7 upstream of
1SFHDT-E
7, and Osh1p in yeast has
1EFFDK-N
7 120aa before
1EFFDA-E
7. Likewise some GLTP and FAPP2 homologues have
two FFAT-like motifs, though none have three. According to the
‘‘fly casting’’ model, a large acidic patch would enhance the initial,
relatively nonspecific electrostatic interaction, allowing a subopti-
mal motif to bind. This enhancement might explain how
substitutions in key residues are tolerated: K
3 and I
4 are only
found in human protrudin and the StART protein Edr-2
respectively, while Y
2 is found in human ORP4 but is otherwise
rare (Table 1 and Figure 3). In each case, these FFAT motifs are
preceded by at least seven closely packed D/Es. AKAP220 is
unique in having two strong FFAT-like motifs. The reasons for this
are obscure, but might be because the two motifs can be either
inhibited (
1EFFDS-D
7) or activated (
1DFVTA-E
7.) by S/T
phosphorylation.
The significance of FAPP2 is that it is the GLTP that transports
GlcCer, and one proposed route of traffic is from the TGN to the
ER [58]. While FAPP2 in some species has a strong enough motif
to plausibly bind VAP, in mammals the FFAT-like motif is less
well preserved than in other animals, so it could only be a very
weak interactor of VAP, and it is unlikely that the FAPP2-VAP
interaction has been positively selected during mammalian
evolution. The ER-related functions of other novel proteins with
FFAT-like motifs are not known. Rab3GAP1 was originally
identified as a GTP-ase activating protein (GAP) specific to Rab3
[69], but recent studies that included all Rab GAPs did not
replicate this finding [70], so the true function of Rab3GAP1 is
open for speculation. Intracellular localizations described for
AKAP220 and AKAP110 do not include the ER [71,72], but
there are roles for PKA/AKAP at that site [43], and Rab32 is
another AKAP, which has been localised to part of the ER [73].
cAMP signalling occurs in highly localized zones ,1 mmi n
diameter [74], so precise targeting of AKAPs is a critical aspect of
cell function.
How many other proteins bind VAP? Based on our results,
which focussed mainly on human proteins, we tentatively suggest a
list of 18 new proteins with possible FFAT-like motifs (Table S3).
The most likely candidates among this list are: Vps13A/C,
rhophilin-1 and Flipt/SLC22A15, all of which contain only
Figure 4. FAPP2 in mammals has a weak FFAT motif. (A) An alignment of #60 a.a. from the region at the amino-terminus of 7 divergent GLTP
sequences and the related region near the middle of 7 divergent FAPP2 sequences (see diagram, top). Three motifs are shown where the core
2FFD
4
is partly conserved. (B) Diagram of the aligned sequences from (A), where the FFAT-like motifs are shown as logos, and those individual motifs that
meet minimal criteria are shown as boxes, where darker shading indicates closer resemblance to the optimal motif (see Tables S2 and S3). The best
FFAT-like motif lies at different positions in different species. The most amino-terminal motif in human FAPP2 is quite weak. (C) 32 amino acids from
FAPP2 in the opossum M. domestica including the FFAT-like motif
1TFFSA-N
7 were expressed as in Figure 1A, together with variants
1 TFFDA-N
7 and
1EFFDA-N
7. While the wild-type (WT) sequence did not target, the variants with D
4 targeted weakly. (D) The dimer of 37 amino acids including the
FFAT-like motif from human FAPP2 with two substitutions
1EFFDT-N
7 (see Table 1) were expressed as in (C), together with a dimer carrying a third
change
1EFFDA-N
7, and a tetramer of
1TFFDT-N
7. While the dimer with E
1/D
4/T
5 failed to target, the E
1/D
4/A
5 version targeted moderately, and the
tetramer with D
4 targeted weakly.
doi:10.1371/journal.pone.0030455.g004
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applied was to exclude motifs occurring in helices, which is based
on findings that FFAT motifs bind VAP in an extended sheet
[15,30]. However, the motif in GLTP is in a 3–10 helix [75,76],
and this motif along with that in Orp3a in Arabidopsis both fail to
meet our criteria for defining motifs (Table S3, bottom), so it is not
clear whether the structural criterion is helpful. Applying our
criteria more loosely, a very long list of even weaker FFAT-like
motifs could be generated (Table S2B). We tested three hits just
below the cut-off, i.e. with more than two suboptimal FFAT
elements (Table 1): microtubule-associated serine/threonine
kinase (MAST205), c-Src, and the ER-targeted Rab-GTPase in
yeast Ypt11p. None of these targeted the ER (data not shown,
Table 1), which lends support to the cut-off for detectable binding
of monomeric proteins being two suboptimal FFAT elements.
However, we realise that we only partially understand what
constitutes an optimal FFAT motif. For example, it is not clear
why the FFAT-like sequence from FAPP2 in opossum failed to
target as monomers even after key residues were ‘‘corrected’’ by
substitution.
Overall, we find that the very short FFAT motif tolerates
considerable substitution, so that physiologically significant FFAT-
like motifs are hard to detect, making it hard to fully map the VAP
interactome. The broad spectrum and diverse intracellular
localizations of proteins with FFAT-like motifs suggest that
VAP-A and VAP-B are major platforms for integrating many
novel inputs into the ER. This shows that we still cannot
accurately predict the physiological significance of the loss of VAP,
for example in motor neuron disease.
Methods
Constructs containing the sequences shown in Table S5 were
cloned by ligating oligonucleotides in a plasmid based on pRS406
expressing GFP-myc from the PHO5 promoter [41]. To express
dimers, plasmid fragments were ligated together to produce GFP-
myc-motif1-myc-motif2. For tetramers, fragments of dimers were
ligated to further duplicate the insert. Plasmids were integrated
into strain TLY251, which has the GAL1/10 promoter upstream
of the coding sequence of SCS2 [14]. Colonies were grown
overnight in 2% galactose, (except for the Osh1p-FFAT
experiment, where a parallel culture contained 2% dextrose as
carbon source), diluted back in the same medium for 6–8 hours to
reach log phase, and examined by live cell confocal microscopy.
Strength of targeting was analyzed by drawing a line 15 pixels
wide across individual nuclear profiles in ImageJ, to produce a line
scan plot (five such plots shown in Figure 1D/E/F). From each
plot the ratio was calculated of mean fluorescence at the nuclear
rims (peak pixel plus one on either side) compared to the average
fluorescence across the central third of the nucleus (equivalent to
‘‘central region’’ in Figure 1D/E/F). The targeting strength ratio
(TSR) was calculated from the average of these ratios $20 cells.
To find FFAT-like motifs with the natural variations E
1RD,
F
2RY, F
3RY, D
4RE, A
5RC, E
7RD, S or T, we screened the
entire UniProtKB/Swiss-Prot database of eukaryotic sequences
using the ScanProsite tool (prosite.expasy.org) using the pattern
[DE]-X(0,5)-[DE]-[FY]-[FY]-[DEST]-[ACST]-X-[DEST], which
ensures at least one acid among the 6 residues upstream of the
desired 128 variant motifs. This generated 100 hits (Table S1). For
a screen of motifs using a wider definition based on our findings,
the UniProtKB/Swiss-Prot database of human sequences was
scanned using, starting with the pattern [DE]-X(0,5)-X-[FY]-
[FYCILMVWH]-[DEST]-[ACST]-X-[DESTGNQ], which al-
lows for extra variation at positions 1, 3, 4 and 7, and produced
.3,000 hits. Other patterns were also used to include more
extreme variants at individual residues. All potential motifs were
then compared to the optimal FFAT to determine how many of
seven elements (6 residues + acidic flank) they lack. Scoring was
based on our analysis of the combination of (1) the effects on
targeting of single mutations, and (2) the natural variation seen in
the ORP family. Firstly, we analysed how to weight the seven
elements. Variation in residues 1/2/3/4/7 had seemingly similar
impact on ER targeting (Table 1 and Figure 3), so we weighted
these elements equally (1 arbitrary unit). By comparison, variation
at position 5 between AC and ST was less significant, while the
variation in charge in the upstream region appeared to be more
significant, so these two elements were weighted at 0.5 and 1.5
units respectively. Secondly, we determined which residues are
partially acceptable, allocating intermediate penalties compared to
maximum penalty at that residue (Table S2A). In addition, we
estimated penalties for highly divergent residues (Table S2A). The
same scoring system (higher score=worse resemblance to FFAT)
was applied to all the FFAT-like motifs we expressed in yeast
(Table 1, final column) and to motifs obtained from alignments
(Table S4).
Structural predictions were made by PSIPRED 3.0 [77], coiled-
coil prediction was made by COILS [78], and phospho-site
prediction was made by Scansite [79]. Alignments with known
structures were made with HHpred [80]. VAPs were aligned with
MUSCLE. To determine evolutionary conservation of FFAT-like
motifs (Table S3), each protein was submitted to BLAST at NCBI
to identify homologues from the non-redundant database.
Supporting Information
Figure S1 Relationship between FFAT motif targeting
the ER and expression of Scs2p. The FFAT-containing
region of Osh1p (residues 687–796) was expressed from pTL377
[14] in TLY251, which was grown either in galactose (+GAL) to
induce maximal expression of yeast VAP (Scs2p), or in dextrose
(+DEX) to repress expression. As in Figure 1, fluorescence was
measured across nuclear profiles to produce targeting strength
ratios, see Table 1.
(TIF)
Figure S2 Possible additional FFAT-like motifs found by
data mining. A. Interactors of VAPB currently listed at
BIOGRID (http://thebiogrid.org/). The bottom 8 were found
in targeted studies of VAP-SNARE interactions, and bind via the
coiled coil and/or transmembrane domain. The top 5 were found
in high-throughput studies. Of these, one has a known FFAT
(ORP9), and two others have FFAT-like motifs that might mediate
the interaction with VAP: USP20 and RMD3 (see parts B and C).
References: 1. Sowa et.al. (2009) Cell 138: 389–403; 2. Gong
et al. (2006) PNAS 103: 6154–6159; 3. Hutchins et al. (2010)
Science 328: 593–599; 4. Nishimura et al. (1999) BBRC 254: 21–
26; 5. Li et al. (2003) JBC 278: 19791–19797. B. A FFAT-like motif
in USP20 is well conserved. An unstructured loop in human
USP20 contains a FFAT-like motif that is marginally suboptimal
(has more than 2 suboptimal elements in most but not all species),
but is well conserved not only in all vertebrates but also in
primitive metazoa such as Trichoplax. A version of the same motif
appears in a more restricted group of USP33 homologues:
vertebrates excluding birds. C. Molecular mechanism underlying
the RMD3-VAP interaction. RMD3 (also called PTPIP51 or
FAM82A2) on the outer mitochondrial membrane binds VAP on
the ER across the ER-mitochondrial contact site [55]. The
molecular basis for the interaction has not been studied, but the
minimal VAP-binding sequence in human RMD3 (light blue)
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optimal, so would not appear in our list of most likely interactors
(Table S3). The motif is well conserved in RMD3 orthologues, and
is more optimal in sea squirt (Ciona intestinalis) and sea anemone
(Nematostella vectensis). The latter motif meets all our criteria for a
strong FFAT-like motif (see Table S3, second section). The motif is
weakest in fish, which have a highly acidic tract in the downstream
region (asterisk). In addition, RMD2 in some species (but not man)
contains a FFAT-motif. Other domains in RMD3 and VAP are:
yellow=trans-membrane domains, grey=tetratricopeptide repeat
domain, red=MSP domain, green=coiled coil.
(TIF)
Figure S3 Residues in VAP that bind FFAT are con-
served well throughout all eukaryotes. The amino-terminal
MSPdomainsofallVAPsinthegenomesofdiversemodelorganisms
(humans-Hs, flies-Dm,w o r m s - Ce, plants-At, fungi-Sc and Sp)w e r e
aligned and coloured according to the CLUSTALX colour scheme.
Arrows above indicate the 11 residues that interact with FFAT in an
NMR study [15], with the nature of interaction indicated below as:
electrostatic (shown as + strong, 6 weaker), nuclear Overhauser
effects (13 overall in 6 different bond pairs involving 4 residues – each
bond pair shown by the number of NOEs), and 9 hydrophobic
interactions (shown as Ø), where two groups of four of these
interactions are in hydrophobic pockets (shown as Ø––Ø—Ø—Ø).
Numbers indicate the residues for human VAP-A and VAP-B. With
the exception of the truncated human VAP-C, 10 of the interacting
residues are all highly conserved from mammals to fungi to plants.
M89 is the sole exception, varying to L in plants, fungi and Farinelli,
one of two VAPs in flies.
(TIF)
Table S1 All sequences with EFFDA-E or any of 127
combinations of allowed residues. 4 sections depend on
starting residues: A=DF…, B=DY…, C=EF…, D=EY…,
each section containing all eukaryotic sequences containing any of
the 32 variants of the FFAT-like motif starting with the two
selected residues. Numbers in column 6 indicate the number of
proteins with a specific motif. In column 7, C, O, RB, R3 and R11
refer to homologues of CERT, OSBP, rdgB, Rab3GAP1 and
rabphilin11 respectively, and numbers in square brackets indicate
where the list contains multiple homologues in the same family.
(PDF)
Table S2 Defining FFAT-like motifs. A. Criteria for FFAT-
like motifs, and determining number of suboptimal elements. Top
row: to be included in the list of possible motifs, sequences of 13
residues (7 in the body of the motif and 6 upstream) were found
that contained at least 5 of the 6 features defined in the search
pattern in the top row. Then, for all motifs, penalties were assigned
to each element depending on how close they match the optimal.
At each position, the strength of penalty for a particular
substitution was judged primarily by the strength of its inhibitory
effect on targeting, and secondarily by its rarity in alignments
within families of proteins containing FFAT-like motifs. Typical
penalties at most positions were 1 unit, except position 5=0.5 unit,
acidic flank: 1.5 units. Notes: u Ø is any hydrophobic residue:
CILMVW. * For the upstream flank, an estimation of its overall
negative charge (D) was made that included the potential to
develop such charge by phosphorylation: each residue in the flank
was assigned a charge value: D/E=1, S/T=0.5, K/R=21, all
others=0. D is the sum of these values, and can vary between +6
to 26. { To allow scoring of unique variants and of mutations that
we introduced, extreme substitutions were given extreme penalties,
particularly in the flank, and positions 2 and 4. B. Overall numbers
of human FFAT-like motifs identified with these criteria. This
table examines the total pool of FFAT-like motifs in human
proteins at PROSITE as having 5 of the 6 criteria in the top row of
Table S2A (n=3052). Among 15 with #1 suboptimal element, 12
had been identified before (ref [14]). Applying the cut-off of #2
suboptimal elements produces 62 new motifs (see Table S3 for
detailed descriptions). An increase in cut-off ($2.5) would lead to
many more FFAT-like motifs being considered, as the number of
motifs approximately doubles for every extra 0.5 sub-optimal
element allowed.
(PDF)
Table S3 Possible new FFAT-like motifs in 18 proteins.
New FFAT-like motifs (and flanking residues) from two groups of
candidate proteins (1) human proteins containing motifs with 2 or
less suboptimal elements (column 4, see Table S3), and (2) proteins
of any species with motifs among the 127 simple variants of FFAT
(see Table S1) were assessed by four criteria: (A) location in
cytoplasm; (B) known not to form a helix in published
crystallographic/NMR structures; (C) specific conservation across
evolution of key FFAT residues compared to adjacent residues in
orthologues of the protein. Poorly conserved residues in ortholo-
gues are underlined. Where residues in evolutionary distant
orthologues fit FFAT better, they are in bold; (D) #2.0 sub-
optimal elements, calculated as in Table S2. 21 motifs passed all
four criteria; these appear in a section at the top bounded with red
tram lines, and are marked with a tick in column 3. Three of these
are already referred to in the text: AKAP110, AKAP220 and
protrudin, leaving 18 new FFAT-like motifs. A second short
section of the table shows the FFAT-like motifs from known VAP
interactors GLTP, Orp3a, USP20 and RMD3 analyzed in the
same manner. All other motifs failed one or more of the criteria,
and are shown grouped according to the criterion they fail.
Alternative names and information on the reasons for failing
criteria are given for each protein.
(PDF)
Table S4 Analysis of suboptimal elements in FFAT-like
motifs described in this study. Scoring criteria developed in
Table S2 were applied to (A) the FFAT-like motifs identified in
GLTPs and FAPPs in Figure 4, and (B) the FFAT-like motifs
identified in Figure 3 in: StART proteins related to Edr2; ORPs in
plants and other species; rabphilin11 homologues; and a variant of
Opi1p.
(PDF)
Table S5 FFAT-like motifs either expressed in this
study or in known VAP-interactors. This table provides
detailed information on sequences listed in Table 1. { All sequences
(uexcept protrudin, USP20 and RMD3, which aer included only for
comparison) were cloned after GFP-myc. The accession numbers
and species of origin (where not human) of the open reading frames
are: Rab3GAP1 - 289547212; AKAP220 - 7671392; AKAP110 -
217416351; Orp1c: Glycine max - 164457637; Orp2a: A. thaliana -
7269100; Fapp2: Monodelphis domestica- - 312283618; Fapp2: Hs -
158706386; MAST205 - 112363080; Src - 4885609; Ypt11p -
82795261 (S. cerevisiae) and protrudin - 50557646. Sequences are
coloured with acids red, S/T orange, basic residues blue. The core
FFAT-like motifs are highlighted in light blue. Variations
introduced for residues in this study are in bold and underlined.
# is the number of amino acids from each target proteins expressed
in this study. * ‘‘changes’’: summarizes changes introduced to the
natural motif. In dimers/tetramers changes were applied to all
copies. " ‘‘gen.6’’: indicates the overall charge (D/E=21; K/
R=+1) in the flanks close to, but excluding, the FFAT-like motif.
1 ‘‘structure’’: is the predicted (if known then in bold) structure in
this region of the protein. ‘‘U’’ means unstructured or extended.
FFAT-Like Motifs
PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e30455Numbers refer to the residues involved in any main structural
feature. { S5 in this motif was substituted with A to prevent any
inhibitory phosphorylation of that site. uFFAT-like motifs of
protrudin, USP20 and RMD3 were not tested in this study, but
are shown for comparison. An alternative FFAT-like motif in
RMD3 is underlined.
(PDF)
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